Current Edition

Current features

Regenerative Medicine: Hype and Hope or Safety and Efficacy?

Regenerative medicine, and the underlying stem cell technology on which it is based, offer considerable hope to patients suffering from trauma and acute or chronic d...
Continue Reading →
news

Fortuna Fix Announces Series B Financing, Adding Amgen Ventures and Macnguyen Family Office as Shareholders

Fortuna Fix, a private, clinical-stage Regenerative Medicine company is aiming to be the first to bring to the clinic a patient's own neural stem cells (autologous) p...
Continue Reading →